Avaloop-L Oral Solution
Marketer
Avaltus Pharmaceutical Pvt.Ltd.
Salt Composition
Lactulose (10gm/15ml)
Overview Avaloop-L Oral Solution
Lactulose oral solution, a sugar-based medication, effectively treats constipation by drawing fluid into the intestines, softening stool for easier passage. It's also prescribed for hepatic encephalopathy, a liver disorder characterized by cognitive impairment, tremors, and reduced alertness. Lactulose can be administered with or without food, always following your physician's instructions. Consistent daily use at the same time(s) maximizes effectiveness. Dosage adjustments may be necessary based on response. Never exceed the prescribed dose, and avoid doubling up on missed doses. Onset of action is typically within 48 hours. Consult your doctor if constipation persists beyond three days. Common, usually mild, side effects include nausea and vomiting, typically resolving within a few days. However, severe diarrhea or electrolyte imbalances warrant immediate medical attention. Inform your doctor of any pre-existing diabetes or lactose intolerance before starting treatment. Prolonged use might require periodic blood tests to monitor electrolyte levels (such as potassium and sodium). Avoid concurrent use with other laxatives. Pregnant or breastfeeding individuals should seek medical advice before using this medication.
Primary Ingredients of Avaloop-L Oral Solution
There is no text provided to rephrase.
Uses of Avaloop-L Oral Solution
Managing constipation and hepatic encephalopathy.
Major Benefits of Avaloop-L Oral Solution:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Consult the product label for complete instructions prior to consumption. Use a measuring cup for accurate dispensing and ingest orally. Ensure thorough shaking before each use. Avaloop-L Oral Solution can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Avaloop-L Oral Solution:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
How to use Avaloop-L Oral Solution:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment length. Consult the product label for detailed instructions prior to ingestion. Use a measuring device for accurate dosing and consume orally. Ensure thorough shaking before each use. Avaloop-L Oral Solution can be ingested with or without food; however, consistent daily timing is recommended.
How Avaloop-L Oral Solution works:
Avaloop-L Oral Solution softens stool by osmotically drawing fluid into the bowel, facilitating easier elimination.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Avaloop-L Oral Solution and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The oral formulation of Avaloop-L is typically deemed safe for use throughout gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The oral formulation of Avaloop-L is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Avaloop-L Oral Solution.
KidneySAFE IF PRESCRIBED
Oral Avaloop-L is likely safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, though data is limited. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Avaloop-L Oral Solution in patients with liver impairment is likely safe. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Avaloop-L Oral Solution :
Omit any missed dose of Avaloop-L Oral Solution and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Avaloop-L Oral Solution
| Label | Value |
|---|---|
| Type of Compound | Artificial double sugar |
| Potential for Dependence | None. |
| Medication Classification | Gastrointestinal tract |
| Mechanism of Action | Hyperosmotic agents/Cathartics |


